| Health / Medical Topics |
Ixazomib
An active metabolite of MLN9708, a second generation, boron containing peptide proteasome inhibitor (PI) with potential antineoplastic activity. Ixazomib binds to and inhibits the 20S catalytic core of the proteasome, thereby blocking the targeted proteolysis normally performed by the proteasome, which results in an accumulation of unwanted or misfolded proteins; disruption of various cell signaling pathways may follow, resulting in the induction of apoptosis. Compared to first generation PIs, second generation PIs may have an improved pharmacokinetic profile with increased potency and less toxicity. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquinated. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used to treat metastatic or locally advanced breast cancer that has not improved after treatment with certain other anticancer…
Denotes the inhabitants of Iwo Jima, a person from there, or their descendants elsewhere.
A procedure in which x-ray images of the kidneys, ureters, and bladder are taken at regular times after a substance that shows…
Human IVL wild-type allele is located in the vicinity of 1q21 and is approximately 3 kb in length. This allele, which encodes…
This gene plays a role in keratinization.
A macrocyclic lactone derived from Streptomyces avermitilis with antiparasitic activity. Ivermectin exerts its anthelmintic effect via activating glutamate-gated chloride channels expressed on…
